Article

Pandemic 2009 Influenza A in Argentina: A Study of 337 Patients on Mechanical Ventilation

Servicio de Terapia Intensiva, Hospital Interzonal de Agudos San Martín de La Plata, La Plata, Buenos Aires, Argentina.
American Journal of Respiratory and Critical Care Medicine (Impact Factor: 11.99). 03/2010; 182(1):41-8. DOI: 10.1164/201001-0037OC
Source: PubMed

ABSTRACT The rapid spread of the 2009 Influenza A (H1N1) around the world underscores the need for a better knowledge of epidemiology, clinical features, outcomes, and mortality predictors, especially in the most severe presentations.
To describe these characteristics in patients with confirmed, probable, and suspected viral pneumonia caused by 2009 influenza A (H1N1) admitted to 35 intensive care units with acute respiratory failure requiring mechanical ventilation in Argentina, between June 3 and September 7.
Inception-cohort study including 337 consecutive adult patients. Data were collected in a form posted on the Argentinian Society of Intensive Care website.
Proportions of confirmed, probable, or suspected cases were 39%, 8%, and 53% and had similar outcomes. APACHE II was 18 +/- 7; age 47 +/- 17 years; 56% were male; and 64% had underlying conditions, with obesity (24%), chronic obstructive respiratory disease (18%), and immunosupression (15%) being the most common. Seven percent were pregnant. On admission, patients had severe hypoxemia (Pa(O(2))/Fi(O(2)) 140 [87-200]), extensive lung radiologic infiltrates (2.87 +/- 1.03 quadrants) and bacterial coinfection, (25%; mostly with Streptococcus pneumoniae). Use of adjuvants such as recruitment maneuvers (40%) and prone positioning (13%), and shock (72%) and acute kidney injury requiring hemodialysis (17%), were frequent. Mortality was 46%, and was similar across all ages. APACHE II, lowest Pa(O(2))/Fi(O(2)), shock, hemodialysis, prone positioning, and S. pneumoniae coinfection independently predicted death.
Patients with 2009 influenza A (H1N1) requiring mechanical ventilation were mostly middle-aged adults, often with comorbidities, and frequently developed severe acute respiratory distress syndrome and multiorgan failure requiring advanced organ support. Case fatality rate was accordingly high.

Download full-text

Full-text

Available from: Ricardo Valentini, Aug 25, 2015
0 Followers
 · 
126 Views
  • Source
    • "The incidence of bacterial pneumonia was 25–56% in patients infected with 2009 pandemic swine influenza H1N1 virus, especially severely ill patients (Dominguez-Cherit et al., 2009; Kumar et al., 2009; Palacios et al., 2009; Estenssoro et al., 2010). Similarly, most fatalities due to seasonal influenza are linked to bacterial super-infections (McCullers, 2006; Lei et al., 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Seasonal influenza virus infections may lead to debilitating disease, and account for significant fatalities annually worldwide. Most of these deaths are attributed to the complications of secondary bacterial pneumonia. Evidence is accumulating to support the notion that neutrophil extracellular traps (NETs) harbor several antibacterial proteins, and trap and kill bacteria. We have previously demonstrated the induction of NETs that contribute to lung tissue injury in severe influenza pneumonia. However, the role of these NETs in secondary bacterial pneumonia is unclear. In this study, we explored whether NETs induced during pulmonary influenza infection have functional significance against infections with and other bacterial and fungal species. Our findings revealed that NETs do not participate in killing of and . Dual viral and bacterial infection elevated the bacterial load compared to animals infected with bacteria alone. Concurrently, enhanced lung pathogenesis was observed in dual-infected mice compared to those challenged with influenza virus or bacteria alone. The intensified NETs in dual-infected mice often appeared as clusters that were frequently filled with partially degraded DNA, as evidenced by punctate histone protein staining. The severe pulmonary pathology and excessive NETs generation in dual infection correlated with exaggerated inflammation and damage to the alveolar-capillary barrier. NETs stimulation did not significantly alter the gene expression of several antimicrobial proteins, and these NETs did not exhibit any bactericidal activity. Fungicidal activity against was observed at similar levels both in presence or absence of NETs. These results substantiate that the NETs released by primary influenza infection do not protect against secondary bacterial infection, but may compromise lung function.
    Frontiers in Immunology 03/2013; 4:56. DOI:10.3389/fimmu.2013.00056
  • Source
    • "Since the first outbreak of a respiratory illness caused by a novel swine-origin influenza A (H1N1) virus in Mexico during late March 2009 [1], several reports were published regarding the fact that it can sometimes lead to rapidly progressive acute respiratory distress syndrome (ARDS), with mortality rates ranging from 17% to 46% [2] [3] [4]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Technological advances improved the practice of "modern" extracorporeal membrane oxygenation (ECMO). In the present report, we describe the experience of a referral ECMO center using portable miniaturized ECMO systems for H1N1-related severe acute respiratory distress syndrome (ARDS). An observational study of all patients with H1N1-associated ARDS treated with ECMO in Hospital S. João (Porto, Portugal) between November 2009 and April 2011 was performed. Extracorporeal membrane oxygenation support was established using either ELS or Cardiohelp systems (Maquet-Cardiopulmonary-AG, Hirrlingen, Germany). Ten adult patients with severe ARDS secondary to H1N1 infection (Pao(2)/fraction of inspired oxygen, 69 mm Hg [56-84]; Murray score, 3.5 [3.5-3.8]) were included, and 60% survived to hospital discharge. Five patients were uneventfully transferred on ECMO from referring hospitals to our center by ambulance. Six patients were treated during the first postpandemic influenza season. All patients were treated with oseltamivir, and 1 received in addition zanamivir. Four patients received corticosteroids. Nosocomial infection was the most common complication (40%). Of the 4 deaths, 2 were caused by hemorrhagic shock; 1, by irreversible multiple organ failure; and 1, by refractory septic shock. In our experience, ECMO support was a valuable therapeutic option for H1N1-related severe ARDS. The use of portable miniaturized systems allowed urgent rescue of patients from referring hospitals and safe interhospital and intrahospital transport during ECMO support.
    Journal of critical care 02/2012; 27(5):454-63. DOI:10.1016/j.jcrc.2012.01.008 · 2.19 Impact Factor
  • Source
    • "A study, performed in 337 Argentinian adult patients with confirmed, probable, or suspected cases of 2009 influenza A/H1N1v admitted to 35 Intensive Care Units with acute respiratory failure requiring mechanical ventilation , demonstrated coexistent bacterial pneumonia on admission in 25% of the patients. Sp was isolated in 35% of these subjects with bacterial coinfection and this pathogen was found to be associated with worst prognosis , despite concurrent antibiotic treatment on admission [9]. Another Argentinian study examined nasopharyngeal swab samples from 199 cases of mild and severe influenza A/H1N1v infection, identifying at least one additional pathogenic agent importance in 152 (76%) samples. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Secondary bacterial pneumonia, particularly sustained by Streptococcus pneumoniae (Sp), represents an important cause of excess mortality during both influenza epidemics and pandemics. The lethal synergism between influenza virus and Sp was first suggested by studies performed on samples collected during autopsy from victims of 1918 influenza pandemic, and recently confirmed by data collected during the 2009 A/H1N1v influenza pandemic. Moreover, researches carried out in animal model contributed to partially clarify the pathogenic mechanisms underlying the synergism between these two etiological agents. Since 2000, a seven-valent pneumococcal conjugate vaccine (PCV7) was introduced in the US, and in the following year in Europe, determining substantial and almost immediate benefits in terms of reduction of invasive pneumococcal disease (IPD) in both vaccinated children and adults through induction of herd protection. Furthermore, several researches have recently demonstrated the capacity of the PCV7 to prevent community-acquired pneumonia (CAP) and, in particular, influenza-associated pneumonia hospitalisations among children. Taking into account the above-mentioned positive results obtained with PCV7, the availability of a new generation of conjugate pneumococcal vaccine with an enlarged antigenic spectrum (i.e. PCV13) offers promising perspectives, to improve the control of influenza through the protection offered against its major complications, particularly CAP, not only in children, but also among adults.
    Journal of preventive medicine and hygiene 09/2011; 52(3):102-6.
Show more